Compare BRVE & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRVE | PAYO |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2026 | 2021 |
| Metric | BRVE | PAYO |
|---|---|---|
| Price | $24.64 | $7.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $7.69 |
| AVG Volume (30 Days) | 321.2K | ★ 4.1M |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $1,052,774,000.00 |
| Revenue This Year | N/A | $7.15 |
| Revenue Next Year | N/A | $10.28 |
| P/E Ratio | ★ N/A | $142.20 |
| Revenue Growth | N/A | ★ 7.68 |
| 52 Week Low | $24.61 | $4.08 |
| 52 Week High | $32.00 | $7.18 |
| Indicator | BRVE | PAYO |
|---|---|---|
| Relative Strength Index (RSI) | 29.61 | 58.58 |
| Support Level | N/A | $7.08 |
| Resistance Level | $29.68 | $7.16 |
| Average True Range (ATR) | 2.06 | 0.03 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 0.55 | 75.00 |
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.